All Episodes
JACC Author Interviews — 54 episodes
Behind the Science: Why Photon-Counting CT Changes Coronary Calcium Imaging | JACC
Behind the Science: What Muscle Health Reveals About Heart Failure Risk | JACC
Behind the Science: Central, Hematological and Peripheral Effects of Sotatercept | JACC
Behind the Science: Can IL-6 Improve Cardiovascular Risk Assessment? Findings From the CCC Study | JACC Author Interviews
Behind the Science: ECG Prediction of Stroke | JACC
Behind The Science: Radiomic Profiling of Epicardial Fat for Heart Failure Prediction | JACC
Behind the Science: Using Coronary Calcium to Improve Lipoprotein(a) Risk Prediction | JACC Author Interviews
Behind the Science: Excess Cardiovascular Mortality Among Black Americans | JACC
DCB vs DES in Noncomplex Coronary Bifurcation Lesions: REC CAGEFREE I | JACC: Cardiovascular Interventions
Side Branch Treatment for Bifurcation Revascularization: KISS Trial | JACC: Cardiovascular Interventions
Behind the Science: NPR-1 Agonist for Resistant Hypertension | JACC Author Interviews
Global Hypertension 2000 to 2020 | JACC Author Interviews
Behind the Science: AI in Cardiovascular Clinical Trials | JACC
Automated Alerts for Valvular Heart Disease: Insights From the ALERT Trial | ACC.26 | JACC
Panel Discussion: Social Drivers of Health | ACC.26 | JACC
Panel Discussion: Artificial Intelligence | ACC.26 | JACC
Behind The Science: Midventricular Obstruction in HCM: An Overlooked High‑Risk Phenotype | JACC Author Interviews
Tocilizumab and Low-dose Dobutamine in Acute MI | JACC Author Interviews
Underrepresentation of Africa in RCTs | JACC Author Interviews
Designing Next-Gen Cardiometabolic Outcome Trials | JACC
Behind the Science: JACC Stats and JACC Data Reports | JACC
Behind the Science: JACC Data Reports | JACC
The Future of Adult Congenital Heart Care in the United States | ACHD Guideline | JACC
Management of ACHD in Low Resource Settings | ACHD Guideline | JACC
What Has Changed | ACHD Guideline | JACC
The 2025 ACHD Guideline From the Early Career Perspective | ACHD Guideline | JACC
Behind The Science: Screening Young Individuals for SCD | JACC
Recommendations for the Treatment of Valvular Heart Disease | ACHD Guideline | JACC
A Surgeon's Perspective | ACHD Guideline | JACC
Sex Differences in Tricuspid Repair During Mitral Surgery | JACC
Cholesterol Management in Women | JACC
Behind the Science: Analysis of Acoramidis on Cumulative CV Outcomes
Enhanced AF Detection Using Apple Watch | JACC Author Interview
Cardiovascular Care and Outcomes 2018-2022 | JACC Author Interview
Behind the Science | Loss of Y Chromosome & CV Events | JACC
Behind the Science: Danicamtiv in Patients With DCM | JACC Author Interviews
Behind the Science: Tricuspid Regurgitation in HFpEF | JACC
Placental Malperfusion in CHD | JACC Author Interview
Alteplase as an Adjunct to Primary PCI | JACC | TCT 2025
The PROCTOR Trial | JACC | TCT 2025
REC-CAGEFREE I Trial: Drug-Coated Balloons vs. Drug-Eluting Stents at 3 Years | JACC | TCT 2025
Advancing TMVR: Insights From the SUMMIT MAC Trial | JACC | TCT 2025
Primary Aldosteronism | HBP Guideline | JACC
Home BP Monitoring | HBP Guideline | JACC
Preventing Preeclampsia | HBP Guideline | JACC
FAME 3 Cost-Effectiveness| JACC | TCT 2025
The Adipokine Hypothesis: A New Unifying Model for HFpEF | JACC Author Interview
Impact of Routine CCTA After Left-Main PCI | JACC | ESC 2025
Obicetrapib and cardiovascular events | JACC | ESC25
The Adipokine Hypothesis: Rethinking Heart Failure With Preserved Ejection Fraction | JACC | ESC 2025
ODYSSEY-HCM | JACC | ESC 2025
DANRSV Effect of RSV Vaccine on Heart Failure | JACC | ESC.25
Obesity, CKM, and HF | JACC | ESC 2025
Clonal Hematopoiesis and Cardiovascular Risk | JACC | ESC 2025